2020 reference board members

2020 - Reference list of hepatitis publications of the VHPB board members

Launch of the Coalition for Global Hepatitis Elimination: a recommendation of the Lancet Gastroenterology & Hepatology Commission. Ward JW, Wiktor SZ, Cooke GS. Lancet Gastroenterol Hepatol. 2020 Jan;5(1):8-10. doi: 10.1016/S2468-1253(19)30319-X.

 

Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth. Posuwan N, Wanlapakorn N, Vongpunsawad S, Sintusek P, Leuridan E, Van Damme P, Poovorawan Y. Vaccine. 2020 Feb 11;38(7):1643-1651. doi: 10.1016/j.vaccine.2019.12.065. Epub 2020 Jan 14. PMID: 31948817.

 

Securing sustainable funding for viral hepatitis elimination plans. Hatzakis A, Lazarus JV, Cholongitas E, Baptista-Leite R, Boucher C, Busoi CS, Deuffic-Burban S, Chhatwal J, Esmat G, Hutchinson S, Malliori MM, Maticic M, Mozalevskis A, Negro F, Papandreou GA, Papatheodoridis GV, Peck-Radosavljevic M, Razavi H, Reic T, Schatz E, Tozun N, Younossi Z, Manns MP. Liver Int. 2020 Feb;40(2):260-270. DOI: 10.1111/liv.14282

 

Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials. Poordad F, Castro RE, Asatryan A, Aguilar H, Cacoub P, Dieterich D, Marinho RT, Carvalho A, Siddique A, Hu YB, Charafeddine M, Bondin M, Khan N, Cohen DE, Felizarta F. J Viral Hepat. 2020 Jan 18. doi: 10.1111/jvh.13261.

 

Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV. Vanwolleghem T, Groothuismink ZMA, Kreefft K, Hung M, Novikov N, Boonstra A. J Hepatol. 2020 Feb 12. pii: S0168-8278(20)30071-4. doi: 10.1016/j.jhep.2020.01.024.

 

Nivolumab and anti-HCV activity, a case report. Wuyts L, Janssens A, Vonghia L, Michielsen P, Raskin J, Driessen A, Van Hees S, Francque S, Vanwolleghem T. Acta Clin Belg. 2020 Mar 17:1-5. doi: 10.1080/17843286.2020.1741897.

 

A pharmacokinetic study to guide dosing of tenofovir disoproxil fumarate during different modalities of renal replacement therapy. Dams K, Burger DM, Weyler J, Francque S, Jorens PG, Vanwolleghem T. Clin Biochem. 2020 Sep;83:86-88. doi: 10.1016/j.clinbiochem.2020.05.015. Epub 2020 May 30. PMID: 32485171

 

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T. JHEP Rep. 2020 Jun;2(3):100113. DOI: 10.1016/j.jhebpr.2020.100113

 

Hepatology in the COVID era: another C virus, again challenging in the liver. Peixe P, Calinas F, Marinho RT. GE Port J Gastroenterol. 2020 Jul;27(4):230-236. doi: 10.1159/000508116.

 

Point-of-Care Tests for Hepatitis B Are Associated with A Higher Linkage to Care and Lower Cost Compared to Venepuncture Sampling During Outreach Screenings in an Asian Migrant Population. Ho E, Michielsen P, Van Damme P, Ieven M, Veldhuijzen I, Vanwolleghem T. Ann Glob Health. 2020 Jul 16;86(1):81. doi: 10.5334/aogh.2848. PMID: 32742939

 

Elimination of hepatitis C in Europe: can WHO targets be achieved? Maticic M, Lombardi A, Mondelli MU, Colombo M, ESCMID Study Group for Viral Hepatitis (ESGVH). Clin Microbiol Infect. 2020 Jul;26(7): 818-823. DOI: 10.1016/j.cmi.2020.01.014

 

Elimination of viral hepatitis: where do we stand in the year 2020? Maticic M, Mondelli MU. Clin Microbiol Infect 2020 Jul;26(7):816-817. DOI: 10.1016/j.cmi.2020.02.029

 

Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium. Koc ÖM, Kremer C, Hens N, Bielen R, Busschots D, Van Damme P, Robaeys G. PLoS One. 2020 Jul 27;15(7):e0234740. doi: 10.1371/journal.pone.0234740. PMID: 32716949; PMCID: PMC7384618.

 

The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data. Palayew A, Stumo SR, Cooke GS, Hutchinson SJ, Jauffret-Roustide M, Maticic M, Harris M, Metwally AM, Razavi H, Lazarus JV, Hep-CORE Study Group. PLoS One. 2020 Jul 28;15(7):e0235715. DOI: 10.1371/journal.pone.0235715.

 

JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection. Zoulim F, Lenz O, Vandenbossche JJ, Talloen W, Verbinnen T, Moscalu I, Streinu-Cercel A, Bourgeois S, Buti M, Crespo J, Manuel Pascasio J, Sarrazin C, Vanwolleghem T, Shukla U, Fry J, Yogaratnam JZ. Gastroenterology. 2020 Aug;159(2):521-533.e9. doi: 10.1053/j.gastro.2020.04.036. Epub 2020 Apr 25. PMID: 32343960

 

The case for simplifying and using absolute targets for viral hepatitis elimination goals. Homie Razavi, Sarah Blach, Devin Razavi-Shearer, Polaris Observatory Collaborators. J Viral Hepat 2020 Sep 26.  doi: 10.1111/jvh.13412.

 

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Jalan R, Moreau R, Cornberg M, Berg T. JHEP Rep. 2020 Oct; 2(5): 100169. DOI: 10.1016/j.jhepr.2020.100169

 

Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection. Mulder MB, de Man RA, Kamar N, Durmaz G, de Bruijne J, Vanwolleghem T, Izopet J, Gandia P, van der Eijk AA, van Gelder T, Hesselink DA, de Winter BCM. J Viral Hepat. 2020 Nov 1. doi: 10.1111/jvh.13432. Online ahead of print. PMID: 33135238

 

Challenges associated with the roll-out of HCC surveillance in sub-Saharan Africa - the case of Uganda. Van Hees S, Muyindike W, Erem G, Ocama P, Seremba E, Paska A, Michielsen P, Okwir M, Vanwolleghem T. J Hepatol. 2020 Nov;73(5):1271-1273. doi: 10.1016/j.jhep.2020.05.045. Epub 2020 Aug 14. PMID: 32800587

 

EASL Policy statement: Drug use and the global hepatitis C elimination goal. Maticic M, Buti M, Craxi A, Leite RB, Negro F, Berg T.  European Association for the Study of the Liver, Geneva: August 2020.

 

Stable HEV IgG seroprevalence in Belgium between 2006 and 2014. Ho E, Schenk J, Hutse V, Suin V, Litzroth A, Blaizot S, Herzog SA, Verburgh V, Jacques M, Rahman A, Michielsen P, Van Damme P, Van Gucht S, Theeten H, Hens N, Vanwolleghem T. J Viral Hepat. 2020 Nov;27(11):1253-1260. doi: 10.1111/jvh.13347. Epub 2020 Jul 12. PMID: 32564516.

 

Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action. Nakitanda AO, Montanari L, Tavoschi L, Mozalevskis A, Duffell E. BMC Public Health. 2020 Nov 9;20(1):1670. doi: 10.1186/s12889-020-09515-6.

 

Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Simões D, Stengaard AR, Combs L, Raben D, EuroTEST COVID-19 impact assessment consortium of partners. Euro Surveill. 2020 Nov;25(47):2001943. doi: 10.2807/1560-7917.ES.2020.25.47.2001943.

 

The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries. Maticic M, Pirnat Z, Leicht A, Zimmermann R, Windelinck T, Jauffret-Roustide M, Duffel E, Tammi T, Schatz E. Harm Reduct J. 2020; 17:89 (nov 19). DOI: 10.1186/s12954-020-00439-3

 

A centralised novel coronavirus telephone helpline: a tool for managing and tracking the nation’s response to the COVID-19 epidemic in Slovenia. Pelicon K, Krajnc I, Petek K, Maticic M. Zdrav Vestn 2020: 89: 702-709. https://doi.org/10.6016/ZdravVestn.3126

 

Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals. Rodríguez-Tajes S, Domínguez A, Carrión JA, Buti M, Quer JC, Morillas RM, López C, Torras X, Baliellas C, Vergara M, Forner M, Zaragoza N, Salò J, Rigau J, Caballeria Ll, Mariño Z, Jané M, Colom J, Forns X, Lens S. Journal of Gastroenterology and Hepatology 2020; in press

 

Can hepatitis A outbreaks in men who have sex with men be controlled? Domínguez A, Forns X. Revista Clínica Española 2020; in press

 

Book Chapter: Ward JW, Hinman AR, Alter HJ. Time for the elimination of hepatitis C virus as a global health threat. In Arias IM, Wolkoff AW, Boyer JL, Shafritz DA, Fausto N, Alter HJ, Cohen DE eds. The Liver: Biology and  Pathobiology. 6th edition, West Sussex UK, John Wiley and sons Ltd. 2020.